| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Tufts University School of Medicine and Sackler School of Biomedical Sciences, Department of Pathology, Boston, MA 02111;
New England Medical Center, Division of Rheumatology/Immunology, Tufts University School of Medicine, Boston, MA 02111
Cytokines produced by subsets of CD4+ T helper cells responding to an infection influences the efficiency with which the host is able to mount a protective immune response. In an attempt to elucidate the population of active cells involved in the propagation of Lyme arthritis we have utilized intracellular cytokine staining to analyze the polyclonal immune response at the single cell level. We have determined the Th phenotype in the synovial fluid of patients with a variety of chronic inflammatory arthritides, including patients representative of the spectrum of Lyme arthritis. Th1 cells dominate the immune response in the synovial fluid of patients with Lyme as well as those with rheumatoid or other types of chronic inflammatory arthritis. In addition, the severity of Lyme arthritis directly correlates with the ratio of Th1 to Th2 cells in the synovial fluid, such that the larger the effusion, the higher the ratio (r = 0.67, p < 0.05). These results suggest that Th1 cells play a direct role in the pathogenesis of the inflammatory process seen in Lyme arthritis, and that Th2 cells modulate the pro-inflammatory response generated by Th1 cells in the joint. Finally, we identify Th1 cells specific for outer surface protein A of Borrelia burgdorferi, the agent of Lyme disease. These cells are restricted to patients with Lyme arthritis and are localized to the joint. Furthermore, they persist in patients with prolonged antibiotic treatment-resistant Lyme arthritis, suggesting the possibility of an autoimmune process.
This article has been cited by other articles:
|
|
 |
|
  E. Tupin, M. R.-E.-I. Benhnia, Y. Kinjo, R. Patsey, C. J. Lena, M. C. Haller, M. J. Caimano, M. Imamura, C.-H. Wong, S. Crotty, et al. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi PNAS, December 16, 2008; 105(50): 19863 - 19868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. van Maldegem, R. van Dijk, T. A. M. Wormhoudt, P. M. Kluin, R. Willemze, L. Cerroni, C. J. M. van Noesel, and R. J. Bende The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment Blood, October 15, 2008; 112(8): 3355 - 3361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Wang, M. M. Petzke, R. Iyer, H. Wu, and I. Schwartz Pattern of Proinflammatory Cytokine Induction in RAW264.7 Mouse Macrophages Is Identical for Virulent and Attenuated Borrelia burgdorferi J. Immunol., June 15, 2008; 180(12): 8306 - 8315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Iliopoulou, J. Alroy, and B. T. Huber CD28 Deficiency Exacerbates Joint Inflammation upon Borrelia burgdorferi Infection, Resulting in the Development of Chronic Lyme Arthritis J. Immunol., December 15, 2007; 179(12): 8076 - 8082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Dame, B. L. Orenzoff, L. E. Palmer, and M. B. Furie IFN-{gamma} Alters the Response of Borrelia burgdorferi-Activated Endothelium to Favor Chronic Inflammation J. Immunol., January 15, 2007; 178(2): 1172 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Hedrick, C. M. Olson Jr., D. B. Conze, T. C. Bates, M. Rincon, and J. Anguita Control of Borrelia burgdorferi-Specific CD4+-T-Cell Effector Function by Interleukin-12- and T-Cell Receptor-Induced p38 Mitogen-Activated Protein Kinase Activity. Infect. Immun., October 1, 2006; 74(10): 5713 - 5717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ghosh, R. Seward, C. E. Costello, B. D. Stollar, and B. T. Huber Autoantibodies from Synovial Lesions in Chronic, Antibiotic Treatment-Resistant Lyme Arthritis Bind Cytokeratin-10 J. Immunol., August 15, 2006; 177(4): 2486 - 2494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ghosh, A. C. Steere, B. D. Stollar, and B. T. Huber In Situ Diversification of the Antibody Repertoire in Chronic Lyme Arthritis Synovium J. Immunol., March 1, 2005; 174(5): 2860 - 2869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. I. Gergel and M. B. Furie Populations of Human T Lymphocytes That Traverse the Vascular Endothelium Stimulated by Borrelia burgdorferi Are Enriched with Cells That Secrete Gamma Interferon Infect. Immun., March 1, 2004; 72(3): 1530 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Willett, A. L. Meyer, E. L. Brown, and B. T. Huber An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope PNAS, February 3, 2004; 101(5): 1303 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Salazar, C. D. Pope, T. J. Sellati, H. M. Feder Jr, T. G. Kiely, K. R. Dardick, R. L. Buckman, M. W. Moore, M. J. Caimano, J. G. Pope, et al. Coevolution of Markers of Innate and Adaptive Immunity in Skin and Peripheral Blood of Patients with Erythema Migrans J. Immunol., September 1, 2003; 171(5): 2660 - 2670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Christopherson, E. L. Munson, D. M. England, C. L. Croke, M. C. Remington, M. L. Molitor, D. J. DeCoster, S. M. Callister, and R. F. Schell Destructive Arthritis in Vaccinated Interferon Gamma-Deficient Mice Challenged with Borrelia burgdorferi: Modulation by Tumor Necrosis Factor Alpha Clin. Vaccine Immunol., January 1, 2003; 10(1): 44 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Steere Lyme Disease N. Engl. J. Med., July 12, 2001; 345(2): 115 - 125. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Moro, J. Bjornsson, E. V. Marietta, E. K. Hofmeister, J. J. Germer, E. Bruinsma, C. S. David, and D. H. Persing Gestational Attenuation of Lyme Arthritis Is Mediated by Progesterone and IL-4 J. Immunol., June 15, 2001; 166(12): 7404 - 7409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Glickstein, M. Edelstein, and J. Z. Dong Gamma Interferon Is Not Required for Arthritis Resistance in the Murine Lyme Disease Model Infect. Immun., June 1, 2001; 69(6): 3737 - 3743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Thomas, J. Anguita, S. W. Barthold, and E. Fikrig Coinfection with Borrelia burgdorferi and the Agent of Human Granulocytic Ehrlichiosis Alters Murine Immune Responses, Pathogen Burden, and Severity of Lyme Arthritis Infect. Immun., May 1, 2001; 69(5): 3359 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Trollmo, A. L. Meyer, A. C. Steere, D. A. Hafler, and B. T. Huber Molecular Mimicry in Lyme Arthritis Demonstrated at the Single Cell Level: LFA-1{{alpha}}L Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells J. Immunol., April 15, 2001; 166(8): 5286 - 5291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Meyer, C. Trollmo, F. Crawford, P. Marrack, A. C. Steere, B. T. Huber, J. Kappler, and D. A. Hafler Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers PNAS, September 22, 2000; (2000) 190335897. [Abstract] [Full Text]
|
|
|
|
|
|
M. D. McKisic, W. L. Redmond, and S. W. Barthold Cutting Edge: T Cell-Mediated Pathology in Murine Lyme Borreliosis J. Immunol., June 15, 2000; 164(12): 6096 - 6099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Brown and S. L. Reiner Experimental Lyme Arthritis in the Absence of Interleukin-4 or Gamma Interferon Infect. Immun., July 1, 1999; 67(7): 3329 - 3333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Talkington and S. P. Nickell Borrelia burgdorferi Spirochetes Induce Mast Cell Activation and Cytokine Release Infect. Immun., March 1, 1999; 67(3): 1107 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Gross, T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z. A. Nagy, J. A. Field, A. C. Steere, and B. T. Huber Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis Science, July 31, 1998; 281(5377): 703 - 706. [Abstract] [Full Text]
|
|
|
|
 |
|
 J S H GASTON Will the increasing prevalence of atopy have a favourable impact on rheumatoid arthritis? Ann Rheum Dis, May 1, 1998; 57(5): 265 - 267. [Full Text]
|
|
|
|
|
|
A. L. Meyer, C. Trollmo, F. Crawford, P. Marrack, A. C. Steere, B. T. Huber, J. Kappler, and D. A. Hafler Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers PNAS, October 10, 2000; 97(21): 11433 - 11438. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
